AP5

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

D-AP5 was the first NMDA receptor antagonist with sub-micromolar potency.

Original languageEnglish (US)
Title of host publicationxPharm
Subtitle of host publicationThe Comprehensive Pharmacology Reference
PublisherElsevier Inc.
Pages1-3
Number of pages3
ISBN (Print)9780080552323
DOIs
StatePublished - Jan 1 2007

Fingerprint

N-Methyl-D-Aspartate Receptors

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Monaghan, D. T. (2007). AP5. In xPharm: The Comprehensive Pharmacology Reference (pp. 1-3). Elsevier Inc.. https://doi.org/10.1016/B978-008055232-3.61242-5

AP5. / Monaghan, Daniel T.

xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., 2007. p. 1-3.

Research output: Chapter in Book/Report/Conference proceedingChapter

Monaghan, DT 2007, AP5. in xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., pp. 1-3. https://doi.org/10.1016/B978-008055232-3.61242-5
Monaghan DT. AP5. In xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc. 2007. p. 1-3 https://doi.org/10.1016/B978-008055232-3.61242-5
Monaghan, Daniel T. / AP5. xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., 2007. pp. 1-3
@inbook{3fe3e7032158418faa1d14ccecd93ef6,
title = "AP5",
abstract = "D-AP5 was the first NMDA receptor antagonist with sub-micromolar potency.",
author = "Monaghan, {Daniel T}",
year = "2007",
month = "1",
day = "1",
doi = "10.1016/B978-008055232-3.61242-5",
language = "English (US)",
isbn = "9780080552323",
pages = "1--3",
booktitle = "xPharm",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - AP5

AU - Monaghan, Daniel T

PY - 2007/1/1

Y1 - 2007/1/1

N2 - D-AP5 was the first NMDA receptor antagonist with sub-micromolar potency.

AB - D-AP5 was the first NMDA receptor antagonist with sub-micromolar potency.

UR - http://www.scopus.com/inward/record.url?scp=84883973462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883973462&partnerID=8YFLogxK

U2 - 10.1016/B978-008055232-3.61242-5

DO - 10.1016/B978-008055232-3.61242-5

M3 - Chapter

SN - 9780080552323

SP - 1

EP - 3

BT - xPharm

PB - Elsevier Inc.

ER -